Clover Biopharmaceuticals will use FlexFactory biomanufacturing platform

| By | | News

Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, has chosen’s FlexFactory, a biomanufacturing platform based on single-use technologies, for its new facility located in Changxing, Zhejiang in China.

The new facility will mainly be used to produce biological fusion protein products, including innovative drugs and biosimilars. This will help Clover Biopharmaceuticals to bring local access to biologic therapies faster, while also opening global markets through the proven track record of FlexFactory in meeting global regulatory requirements and quality standards. The biomanufacturing facility includes two 2,000 liter bioreactors from GE, and it will be operational in the latter half of 2018.

Clover Biopharmaceuticals’ new production facility will be located in one of the national economic development zones in China, Changxing Economic and Technological Development Zone, where a new biopharmaceutical industrial cluster is being developed. China has a broader strategy on biotechnological innovation per the government’s 13th Five-Year Plan, and there are plans to build up to twenty science parks for biomedicine by 2020 to accelerate local research and development activities. In 2015, the Chinese biopharmaceutical market was valued approximately at $13 billion, and the estimated annual growth rate (CAGR) is around 13 percent for the next few years.

“Adopting high-quality technologies and driving innovation in our manufacturing operations is important for Clover Biopharmaceuticals. GE’s FlexFactory represents the latest in biomanufacturing technologies, and it will help us establish flexible production capacity quickly, while fulfilling good manufacturing practices (GMP) requirements,” said Dr. Peng Liang, Co-founder, Chairman and President of Clover Biopharmaceuticals.

General Electric Healthcare is a leading provider of medical imaging equipment, with a track record of more than 100 years in the industry.

SOURCE: ge
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.